SBIR Phase II: Exploring Complex Biological Concepts in an Interactive 3-D Learning Environment over the Internet

这个小企业创新研究二期项目将创建一个3D交互式学习系统，用于交流生物和医学科学中复杂的科学概念，这些概念很难通过冗长的叙事脚本来掌握。在第一阶段制定的详细技术规范将被开发成不同于今天可用的软件解决方案。这个学习工具允许用户在可视化上下文中查询对象，其中可以操作这些对象的特定方面。Syandus采用了电子游戏中常见的复杂实时3D渲染技术：1)通过创建与时间驱动的交互能力，复杂科学现象的3D过程模型；2)通过将文本信息与这些可视化对象和过程相关联。当用户点击鼠标时，对象就会智能地以深度分层的文本、插图和链接文件的形式显示它们的含义。该接口可以聚合各种信息，例如一家制药公司关于某种疾病的所有技术信息。最后，Syandus正在构建通过标准浏览器界面或从CDROM启动并通过窄带互联网连接自动更新的软件。药品之间的区别日益以迅速发展的复杂科学为基础，因此必须有一种机制来收集和交流与药物如何对疾病状态起作用有关的科学信息。Syandus将制药行业作为公司的第一个目标市场，计划创建一种工具，帮助医生了解治疗对人们生活产生不利影响的复杂疾病状态的突破性药物。该公司的定制项目将为医学生、专业人士和医疗保健消费者带来持久的资源。随着技术的成熟，该公司将进军高等教育市场。通过互联网连接，该产品可以在全球范围内获得广泛的受众。

This Small Business Innovation Research Phase II project will create a 3D, interactive learning system to communicate complex scientific concepts from biological and medical science, which are difficult to grasp via long narrative scripts. The detailed technical specifications formulated in Phase I will be developed into a software solution distinctive from what is available today. This learning tool allows the user to inquire about objects in a visualization context, where specific aspects of these objects can be manipulated. Syandus has adapted sophisticated real-time 3D rendering technology common to video games as follows: 1) by creating the ability to interact with time driven, 3D process models of complex scientific phenomena; and 2) by associating textual information with these visualized objects and processes. At a user's mouse click, objects intelligently reveal what they are about in deeply layered text, illustrations and linked files. This interface can aggregate all kinds of information, such as all of a pharmaceutical company's technical information on a disease. Finally, Syandus is building the software to be delivered across the Internet through a standard browser interface or launched from a CDROM and automatically updated via a narrowband Internet connection. The differentiation among pharmaceutical products is ever increasingly grounded in rapidly evolving complex science, thus making essential a mechanism for aggregating and communicating scientific information that relates how drugs work to disease states. Focusing on the pharmaceutical industry as the firm's first target market, Syandus proposes to create a tool to help physicians understand the breakthrough medicines to treat complex disease states that adversely impact people's lives. The firm's custom projects will result in enduring resources for medical students, professionals and healthcare consumers. As the technology matures, the firm will pursue higher education markets. Through Internet connectivity, the product can reach wide audiences across the globe.